Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
6 March 2015
E-003766-15
Question for written answer
to the Commission
Rule 130
Sirpa Pietikäinen (PPE)

 Subject:  Validation process for alternatives to animal testing
 Answer(s) 

The increased availability of alternatives to animal testing is a primary goal of Regulation (EC) No 1907/2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) and of Regulation (EC) No 1223/2009 on cosmetic products. The validation of such approaches appears to have reached a bottleneck, becoming a lengthy and costly process. The current concepts of validation were developed almost 25 years ago.

Is the Commission considering revisions of the validation process to accelerate and adapt it to the new technologies that have emerged since it was first developed?

How will the Commission financially enable the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) of the Joint Research Centre (JRC) to expand its scope of work to basic research as mandated by Directive 2010/63/EU on the protection of animals used for scientific purposes?

Last updated: 17 March 2015Legal notice